Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 22c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.10, $0.22 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Eton Pharmaceuticals (ETON) PT Raised to $65 at H.C. Wainwright
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Movano (MOVE) Misses Q2 EPS by 195c